Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial

P. Kosmidis, Nick Mylonakis, C. Nicolaides, C. Kalophonos, Epaminontas Samantas, J. Boukovinas, George Fountzilas, Dimosthenis Skarlos, T. Economopoulos, D. Tsavdaridis,

Journal of Clinical Oncology · 2002 · 255 citations · 28 references

Abstract

The PG combination is as equally active and well tolerated as the PC combination in patients with advanced NSCLC.

References

28